AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $397,000 | -20.4% | 45,004 | -10.0% | 0.95% | -12.4% |
| Q2 2018 | $499,000 | +4.6% | 50,004 | 0.0% | 1.08% | +15.6% |
| Q1 2018 | $477,000 | +52.9% | 50,004 | +138.0% | 0.94% | +246.7% |
| Q4 2017 | $312,000 | -24.5% | 21,009 | 0.0% | 0.27% | -27.2% |
| Q3 2017 | $413,000 | +36.8% | 21,009 | 0.0% | 0.37% | +33.9% |
| Q2 2017 | $302,000 | -22.0% | 21,009 | -50.0% | 0.28% | -3.5% |
| Q1 2017 | $387,000 | – | 42,019 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |